Lichen Planopilaris Drugs Market: Corticosteroids is expected to be the leading segment during the forecast period

24 Sep 2021
www.biospace.com
Lichen Planopilaris: Introduction Lichen planopilaris is a medical condition that causes scarring hair loss. It causes swelling and irritation on the skin, nails, and mucous membrane. It forms lacy white patches on mucous membrane, while on the skin it appears as reddish color, itchy, and flat bumps. Lichen planopilaris replaces the hair follicle on skin with scarring. It is most common in women than men. It is two to five times more prevalent in women than men and affects adults in their mid-40s. Common symptoms of lichen planopilaris include itchy scalp, pain, burning, and scalp tenderness. It also causes painful sores in the mouth and genial parts. Read Report Overview - Generally, symptoms of lichen planopilaris disappear naturally in a few months. However, medical treatment is required where it affects the mucous membrane. Common treatments include corticosteroids, oral anti-infective, immune response medicines, and antihistamines. Key Drivers of Global Lichen Planopilaris Drugs Market The global lichen planopilaris drugs market is primarily driven by high prevalence of lichen planopilaris. Around 1% of the world’s population is affected by lichen planopilaris. People affected with hepatitis C are more susceptible to the condition. Hence, increase in the number of patients with hepatitis C is another key driver of the global lichen planopilaris drugs market. Launch of pipeline drugs during the forecast period is anticipated to contribute to the growth of the global lichen planopilaris drugs market Request Brochure of Report - Corticosteroids Segment to be Highly Promising Based on drug type, the global planopilaris drugs market can be divided into antihistamines, corticosteroids, anti-infection drugs, immunomodulators, and others. Corticosteroids is expected to be the leading segment during the forecast period. Corticosteroids are used as first-line treatment for lichen planopilaris and inflammatory disorders. Topical corticosteroid preparations are most commonly used in the treatment of the condition. Corticosteroid drugs are utilized to relieve the symptoms of itching and rashes. Immunomodulators are used in the treatment of severe cases of lichen planopilaris. Commonly used immunomodulators are azathioprine, mycophenolate, cyclosporine, and methotrexate. Antihistamine drugs are used to reduce itching, rashes, and redness of skin Topical Segment to Dominate Global Market In terms of route of administration, the global lichen planopilaris drugs market can be classified into oral, topical, and others. The topical segment is likely to dominate the global market during the forecast period. Topical is the most commonly used and preferred route of administration of the treatment of lichen planopilaris Oral is likely to be fastest growing segment during the forecast period Request for Custom Research - Retail Pharmacies to be Most Promising Segment Based on distribution channel, the global lichen planopilaris drugs market can be divided into hospital pharmacies, retail pharmacies, and online pharmacies. The retail pharmacies segment accounted for significant market share in 2020. The segment is projected to witness strong growth during the forecast period. Increase in the number of lichen planopilaris drugs dispensed through retail pharmacies and rise in the number of retail pharmacies in developing countries render these pharmacies as a major distribution channel. Moreover, patients prefer retail pharmacies to purchase drugs, as these are easily accessible. Asia Pacific to Dominate Global Lichen Planopilaris Drugs Market In terms of region, the global lichen planopilaris drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period. However, the region is anticipated to lose market share by the end of 2027. High prevalence of lichen planopilaris in adults and high awareness and easy availability of medications are expected to drive the lichen planopilaris drugs market in North America during the forecast period The lichen planopilaris drugs market in Asia Pacific is projected to expand at a high CAGR during the forecast period. Growth of the market in Asia Pacific can be attributed to high prevalence of lichen planopilaris in densely populated countries such as India, China, and Hong Kong, rapidly improving health care infrastructure, and significantly high infection rate of hepatitis C. Pre Book Lichen Planopilaris Drugs Market Report at Key Manufacturers Operating in Global Lichen Planopilaris Drugs Market The global lichen planopilaris drugs market was highly fragmented in 2020. Key manufacturers operating in the global market are: Sanofi S.A. Teva Pharmaceutical Industries Mylan NV Aurobindo Pharma Limited Pfizer, Inc. Salix Pharmaceuticals, Inc. GlaxoSmithKline plc F. Hoffmann-La Roche AG Eli Lilly and Company Bausch Health Companies, Inc. Other prominent players Browse more Reports by Transparency Market Research: Veterinary Ultrasound Scanners Market: Ultrasound does not use radiation like other imaging modalities, so it is one of the preferred viewing option during pregnancy. Ultrasound equipment used for animals are mostly similar to humans, except they use higher frequency and smaller size of probes. Laboratory Centrifuge Market: The widening applications of laboratory centrifuges are expected to drive the global market in the coming years. The growing number of diagnostic centers is expected to be the key growth driver for the global market. Medical Connectors Market: Extensive research and development in the healthcare industry is leading to the development of new devices and medical equipment. These devices and equipment are being connected to several other equipment and devices, thereby driving the need for better medical connectors. About Us Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision. Contact Mr. Rohit Bhisey Transparency Market Research State Tower, 90 State Street, Suite 700, Albany NY - 12207 United States USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website:
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.